Skip to main content
Caplight Logo









InterShunt Technologies

InterShunt Technologies

Private
Maple Grove, MinnesotaHealthcare & Life Scienceshttps://www.intershunt.com/

Last Round

Series B

Aug 13, 2024

Total Funding Raised

$18.3M

Company Overview

InterShunt Technologies is a medical device company developing a proprietary, minimally invasive transcatheter system to create an interatrial shunt for relieving elevated left atrial pressure in heart failure patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

atrial shuntheart failure treatmentimplant-free devicetranscatheter systemleft atrial pressureminimally invasive devicestructural heart deviceinterventional cardiologyMedTechtissue excisionsingle-use medical deviceheart failure with reduced ejection fractionHFrEF

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InterShunt Technologies Comparables

Compare InterShunt Technologies with similar companies based on industry and business-model similarity.

InterShunt Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alleviant Medical
88%
Corvia Medical
83%
Adona Medical
81%

InterShunt Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 13, 2024
Series AJan 11, 2021

Key People

Founding team and executive leadership

Harlee Sorkin

CEO

Executive Team

InterShunt Technologies Investors

Notable investors and investment history

InterShunt Technologies investors
InvestorRounds
Solas BioVenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 13, 2024

    $18.3M round completed.

InterShunt Technologies Filings

Explore SEC and related filing metadata, where available.

InterShunt Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InterShunt Technologies's valuation, stock price, and market status.

Is InterShunt Technologies a public or private company?

InterShunt Technologies is a private company.

What is the current stock price of InterShunt Technologies?

InterShunt Technologies is a private company with no public stock price. No recent secondary market data is available.

How much is InterShunt Technologies worth (valuation)?

Valuation information for InterShunt Technologies is not publicly available.

Can I buy InterShunt Technologies stock?

InterShunt Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was InterShunt Technologies's last funding round?

InterShunt Technologies's most recent funding round was Series B on August 13, 2024.

Who are the main investors in InterShunt Technologies?

Key investors in InterShunt Technologies include Solas BioVentures.

Will InterShunt Technologies IPO soon?

No public IPO plans have been announced for InterShunt Technologies.

How can I track InterShunt Technologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InterShunt Technologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMaple Grove, Minnesota
Employee Range8
Year Founded2015
Last FundingAug 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?